You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

high tumor burden

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Follicular Lymphoma, Tumor Trial in Houston (Obinutuzumab, CC-99282)

Not yet recruiting
  • Follicular Lymphoma
  • Tumor
  • Houston, Texas
    M D Anderson Cancer Center
Oct 30, 2023

Cohort Studies Trial in Jinan (apantamide+docetaxel+ADT, apantamide+ADT treatment)

Recruiting
  • Cohort Studies
  • Jinan, Shandong, China
    Qilu hospital
Feb 3, 2023

Follicular Lymphoma Trial (Bendamustine, Rituximab, Tazemetostat)

Not yet recruiting
  • Follicular Lymphoma
  • (no location specified)
Dec 15, 2022

Metastatic Hormone-Sensitive Prostate Cancer (mHSPC) Trial in Nanjing (6-month course of antiandrogen drugs, Long-term course of

Recruiting
  • Metastatic Hormone-Sensitive Prostate Cancer (mHSPC)
  • 6-month course of antiandrogen drugs
  • Long-term course of antiandrogen drugs
  • Nanjing, Jiangsu, China
    Urology dpt, First Affiliated Hospital of Nanjing Medical Univer
Jul 13, 2023

Abemaciclib in Combination With Endocrine Therapy as First Line

Recruiting
  • Breast Cancer/ Metastatic Breast Cancer
  • Munich, Germany
    Klinikum rechts der Isar der TU München, Klinik und Poliklinik f
Apr 26, 2022

Diffuse Large B Cell Lymphoma, Follicular Lymphoma Grade 3B Trial in Changchun (R-CDOP)

Recruiting
  • Diffuse Large B Cell Lymphoma
  • Follicular Lymphoma Grade 3B
  • R-CDOP
  • Changchun, Jilin, China
    The First Bethune Hospital of Jilin University
Sep 15, 2021

Lymphoblastic Leukemia, Acute, Childhood Trial in Philadelphia (Tocilizumab, CART 19)

Completed
  • Lymphoblastic Leukemia, Acute, Childhood
  • Philadelphia, Pennsylvania
    Children's Hospital of Philadelphia
Jun 30, 2021

Metastatic Breast Cancer Trial in Seoul (Pembrolizumab)

Not yet recruiting
  • Metastatic Breast Cancer
  • Seoul, Korea, Republic of
    Yonsei Cancer Center at Yonsei University Health System
Mar 14, 2022

Follicular Lymphoma Trial in Germany (Copanlisib, Obinutuzumab)

Recruiting
  • Follicular Lymphoma
  • München, Bavaria, Germany
  • +39 more
May 19, 2022

Indolent Non-Hodgkin Lymphoma Trial in München (Ibrutinib, GA 101)

Active, not recruiting
  • Indolent Non-Hodgkin Lymphoma
  • München, Bavaria, Germany
    Klinikum der Universität München
May 6, 2021

Lenalidomide With Tumor Flare Reaction and High Tumor Burden in

Recruiting
  • Lymphoma, Mantle-Cell
  • Graz, Austria
  • +86 more
Oct 19, 2022

Ovarian Cancer Trial (Cytoreductive Surgery (CRS), Hyperthermic Intraperitoneal Chemotherapy (HIPEC), Neoadjuvant Chemotherapy

Completed
  • Ovarian Cancer
  • Cytoreductive Surgery (CRS)
  • +4 more
  • (no location specified)
Mar 17, 2021

Mantle Cell Lymphoma, Ketogenic Dieting Trial in New York (Ketogenic Diet)

Recruiting
  • Mantle Cell Lymphoma
  • Ketogenic Dieting
  • Ketogenic Diet
  • New York, New York
    Weill Cornell Medicine
Oct 17, 2022

Primary Tumor Burden Score:A Novel Staging Parameter for ESCC

Completed
  • Neoplasm, Esophagus
  • Neoplasm, Squamous Cell
  • nCRT
  • (no location specified)
Apr 20, 2023

Cognitive Burden Trial in Chapel Hill (Artificial Intelligence)

Not yet recruiting
  • Cognitive Burden
  • Artificial Intelligence
  • Chapel Hill, North Carolina
    Lineberger Comprehensive Cancer Center
Aug 29, 2023

Pan Tumor Trial in Worldwide (Nivolumab, Ipilimumab)

Active, not recruiting
  • Pan Tumor
  • Nivolumab
  • Ipilimumab
  • Santa Monica, California
  • +59 more
Jul 26, 2022

Follicular Lymphoma Trial in Italy (Immunochemo regimen: Rituximab-bendamustine (Arm A), Immunochemo regimen:

Recruiting
  • Follicular Lymphoma
  • Immunochemotherapy regimen: Rituximab-bendamustine (Arm A)
  • +9 more
  • Barletta, Barletta Andria Trani, Italy
  • +68 more
Oct 13, 2022

Neurofibromatosis 1, Neurofibroma, Atypical Neurofibroma Trial in Washington (Whole Body MRI)

Active, not recruiting
  • Neurofibromatosis 1
  • +5 more
  • Whole Body MRI
  • Washington, District of Columbia
    Children's National Health System
Feb 26, 2021

Colorectal Cancer Trial in Beijing (Fruquintinib and Sintilimab)

Recruiting
  • Colorectal Cancer
  • Fruquintinib and Sintilimab
  • Beijing, Beijing, China
    Chinese Academy of Medical Sciences
Jan 5, 2021

From Patients With High Grade Gliomas

Recruiting
  • High Grade Glioma
  • Radiotherapy as per standard of care
  • Toronto, Ontario, Canada
    University Health Network
Jun 21, 2023

Coronary Thrombosis Trial (Primary Percutaneous coronary angiography)

Not yet recruiting
  • Coronary Thrombosis
  • Primary Percutaneous coronary angiography
  • (no location specified)
Dec 3, 2022

Cancer, Solid Tumor, Patient Empowerment Trial in Philadelphia (Text triage)

Completed
  • Cancer
  • +3 more
  • Text triage
  • Philadelphia, Pennsylvania
    Perelman Center for Advanced Care
Jan 31, 2023

Primary Brain Tumor, Caregiver Burden, Self Care Trial in Kayseri (home care)

Completed
  • Primary Brain Tumor
  • +2 more
  • home care
  • Kayseri, Eyalet/Yerleşke, Turkey
    Erciyes University Faculty of Health Science
Apr 7, 2022

Non Small Cell Lung Cancer Trial in Spain (Atezolizumab-Bevacizumab)

Active, not recruiting
  • Non Small Cell Lung Cancer
  • Santiago De Compostela, A Coruña, Spain
  • +24 more
Jun 1, 2022

Neuroblastoma, CNS Tumor, Sarcoma Trial in Columbus (Cabozantinib)

Recruiting
  • Neuroblastoma
  • +2 more
  • Columbus, Ohio
    Nationwide Children's Hospital
Dec 20, 2022